Synthesis of coagulation factors during long‐term ex situ liver perfusion. Issue 2 (30th July 2021)
- Record Type:
- Journal Article
- Title:
- Synthesis of coagulation factors during long‐term ex situ liver perfusion. Issue 2 (30th July 2021)
- Main Title:
- Synthesis of coagulation factors during long‐term ex situ liver perfusion
- Authors:
- Eshmuminov, Dilmurodjon
Hefti, Max
Mueller, Matteo
Schuler, Martin J.
Bautista Borrego, Lucia
Schneider, Marcel André
Koch, Karin
Weisskopf, Miriam
Tibbitt, Mark W.
Dutkowski, Philipp
Rudolf von Rohr, Philipp
Studt, Jan‐Dirk
Becker, Dustin
Clavien, Pierre‐Alain - Abstract:
- Abstract: Robust viability assessment of grafts during normothermic liver perfusion is a prerequisite for organ use. Coagulation parameters are used commonly for liver assessment in patients. However, they are not yet included in viability assessment during ex situ perfusion. In this study, we analysed coagulation parameters during one week ex situ perfusion at 34℃. Eight discarded human livers were perfused with blood‐based, heparinised perfusate for one week; perfusions in a further four livers were terminated on day 4 due to massive ongoing cell death. Coagulation parameters were well below the physiologic range at perfusion start. Physiologic levels were achieved within the first two perfusion days for factor V (68.5 ± 35.5%), factor VII (83.5 ± 26.2%), fibrinogen (2.1 ± 0.4 g/L) and antithrombin (107 ± 26.5%) in the livers perfused for one week. Despite the increased production of coagulation factors, INR was detectable only at 24h of perfusion (2.1 ± 0.3) and prolonged thereafter (INR > 9). The prolongation of INR was related to the high heparin level in the perfusate (anti‐FXa > 3 U/mL). Intriguingly, livers with ongoing massive cell death also disclosed synthesis of factor V and improved INR. In summary, perfused livers were able to produce coagulation factors at a physiological level ex situ. We propose that single coagulation factor analysis is more reliable for assessing the synthetic function of perfused livers as compared to INR when using a heparinisedAbstract: Robust viability assessment of grafts during normothermic liver perfusion is a prerequisite for organ use. Coagulation parameters are used commonly for liver assessment in patients. However, they are not yet included in viability assessment during ex situ perfusion. In this study, we analysed coagulation parameters during one week ex situ perfusion at 34℃. Eight discarded human livers were perfused with blood‐based, heparinised perfusate for one week; perfusions in a further four livers were terminated on day 4 due to massive ongoing cell death. Coagulation parameters were well below the physiologic range at perfusion start. Physiologic levels were achieved within the first two perfusion days for factor V (68.5 ± 35.5%), factor VII (83.5 ± 26.2%), fibrinogen (2.1 ± 0.4 g/L) and antithrombin (107 ± 26.5%) in the livers perfused for one week. Despite the increased production of coagulation factors, INR was detectable only at 24h of perfusion (2.1 ± 0.3) and prolonged thereafter (INR > 9). The prolongation of INR was related to the high heparin level in the perfusate (anti‐FXa > 3 U/mL). Intriguingly, livers with ongoing massive cell death also disclosed synthesis of factor V and improved INR. In summary, perfused livers were able to produce coagulation factors at a physiological level ex situ. We propose that single coagulation factor analysis is more reliable for assessing the synthetic function of perfused livers as compared to INR when using a heparinised perfusate. Abstract : Discarded livers are able to regain and to maintain their capacity to produce coagulation factors at a physiological level during ex situ machine perfusion for one week. We propose that single coagulation factor analysis is more reliable for assessing the synthetic function of perfused livers prior transplantation compared to INR in a heparinized perfusate. … (more)
- Is Part Of:
- Artificial organs. Volume 46:Issue 2(2022)
- Journal:
- Artificial organs
- Issue:
- Volume 46:Issue 2(2022)
- Issue Display:
- Volume 46, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 46
- Issue:
- 2
- Issue Sort Value:
- 2022-0046-0002-0000
- Page Start:
- 273
- Page End:
- 280
- Publication Date:
- 2021-07-30
- Subjects:
- coagulation factors -- ex situ -- liver perfusion -- synthetic function
Artificial organs -- Periodicals
617.956 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1525-1594 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=aor ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1111/aor.14041 ↗
- Languages:
- English
- ISSNs:
- 0160-564X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1735.052000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26953.xml